Pharmacokinetic Considerations in Rational Drug Design

Overview

Journal Clin Pharmacokinet

Specialty Pharmacology

Date 1994 Mar 1

PMID 8194280

Citations 2

Authors

M Gumbleton

W Sneader

Affiliations

Soon will be listed here.

Citing Articles

Lack of in vitro-in vivo correlation of a novel investigational anticancer agent, SH 30.

Poondru S, Parchment R, Purohit V, LoRusso P, Horwitz J, Hazeldine S Invest New Drugs. 2002; 20(1):23-33.

PMID: 12003192 DOI: 10.1023/a:1014457510073.

The influence of food on the absorption and metabolism of drugs: an update.

Williams L, Hill Jr D, Davis J, Lowenthal D Eur J Drug Metab Pharmacokinet. 1996; 21(3):201-11.

PMID: 8980916 DOI: 10.1007/BF03189714.

References

Lund Laursen A, Gerlach J . Antipsychotic effect of remoxipride, a new substituted benzamide with selective antidopaminergic activity. Acta Psychiatr Scand. 1986; 73(1):17-21. DOI: 10.1111/j.1600-0447.1986.tb02659.x. View

Stella V, Charman W, Naringrekar V . Prodrugs. Do they have advantages in clinical practice?. Drugs. 1985; 29(5):455-73. DOI: 10.2165/00003495-198529050-00002. View

Fuhr U, Strobl G, Manaut F, Anders E, Sorgel F, Chu D . Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2. Mol Pharmacol. 1993; 43(2):191-9. View

Sjoberg P, Olofsson I, Lundqvist T . Validation of different microdialysis methods for the determination of unbound steady-state concentrations of theophylline in blood and brain tissue. Pharm Res. 1992; 9(12):1592-8. DOI: 10.1023/a:1015816509140. View

BOHNI E, FUST B, Rieder J, SCHAERER K, Havas L . Comparative toxicological, chemotherapeutic and pharmacokinetic studies with sulphormethoxine and other sulphonamides in animals and man. Chemotherapy. 1969; 14(4):195-226. DOI: 10.1159/000220630. View

Hogberg T, Ramsby S, de Paulis T, Stensland B, Csoregh I, Wagner A . Solid state conformations and antidopaminergic effects of remoxipride hydrochloride and a closely related salicylamide, FLA 797, in relation to dopamine receptor models. Mol Pharmacol. 1986; 30(4):345-51. View

Dietzel K, Keuth V, Estes K, Brewster M, Clemmons R, Vistelle R . A redox-based system that enhances delivery of estradiol to the brain: pharmacokinetic evaluation in the dog. Pharm Res. 1990; 7(8):879-83. DOI: 10.1023/a:1015977319212. View

Dross K . The metabolites of 14C-sulpiride in the rat. Arzneimittelforschung. 1978; 28(5):824-7. View

HERTING R, Lopez F, SCHERFLING E, SYLVESTER J, Wiegand R . CLINICAL PHARMACOLOGY OF 2-SULFANILAMIDO-3-METHOXYPYRAZINE. Antimicrob Agents Chemother (Bethesda). 1964; 10:554-61. View

10.

Conradi R, Hilgers A, Ho N, Burton P . The influence of peptide structure on transport across Caco-2 cells. Pharm Res. 1991; 8(12):1453-60. DOI: 10.1023/a:1015825912542. View

11.

Ginsburg C, McCracken Jr G, Petruska M, Olson K . Pharmacokinetics and bactericidal activity of cefuroxime axetil. Antimicrob Agents Chemother. 1985; 28(4):504-7. PMC: 180292. DOI: 10.1128/AAC.28.4.504. View

12.

Sitar D, Warren C, Aoki F . Pharmacokinetics and pharmacodynamics of bambuterol, a long-acting bronchodilator pro-drug of terbutaline, in young and elderly patients with asthma. Clin Pharmacol Ther. 1992; 52(3):297-306. DOI: 10.1038/clpt.1992.145. View

13.

Bergman J, Persson H, Wetterlin K . 2 new groups of selective stimulants of adrenergic beta-receptors. Experientia. 1969; 25(9):899-901. DOI: 10.1007/BF01898049. View

14.

Harding S, Williams P, Ayrton J . Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers. Antimicrob Agents Chemother. 1984; 25(1):78-82. PMC: 185439. DOI: 10.1128/AAC.25.1.78. View

15.

Vree T, Hekster Y, Damsma J, Tijhuis M, Friesen W . Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion. Eur J Clin Pharmacol. 1981; 20(4):283-92. DOI: 10.1007/BF00618779. View

16.

Mordenti J . Man versus beast: pharmacokinetic scaling in mammals. J Pharm Sci. 1986; 75(11):1028-40. DOI: 10.1002/jps.2600751104. View

17.

Fromson J . A phased approach to drug development. J Pharmacokinet Biopharm. 1989; 17(4):509-21; discussion 521-3. DOI: 10.1007/BF01061460. View

18.

Smith D . Species differences in metabolism and pharmacokinetics: are we close to an understanding?. Drug Metab Rev. 1991; 23(3-4):355-73. DOI: 10.3109/03602539109029764. View

19.

Regardh C, Gabrielsson M, Hoffman K, Lofberg I, Skanberg I . Pharmacokinetics and metabolism of omeprazole in animals and man--an overview. Scand J Gastroenterol Suppl. 1985; 108:79-94. DOI: 10.3109/00365528509095821. View

20.

HUMPHREY M, Smith D . Role of metabolism and pharmacokinetic studies in the discovery of new drugs--present and future perspectives. Xenobiotica. 1992; 22(7):743-55. DOI: 10.3109/00498259209053137. View